Bakhos A. Tannous, PhD

May is Brain Tumor Awareness Month. @AstraZeneca and @AlexionPharmaUS , we are committed to advancing rare oncology research—including brain tumors—where innovation can make the greatest impact on patients and families.
#BrainTumorAwareness #RareDisease #Oncology #Innovation

Online Now: Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunity dlvr.it/TSKVFp

We're fueling your Friday with positivity and motivation

Online Now: A photoreceptor state links aggressive brain tumors in children dlvr.it/TRbCvd

CAR T cells are laboratory-engineered immune cells that provide effective treatment for some cancers. Progress is being made towards creating these cells in vivo go.nature.com/3NtYGY4

#Thanksgiving is not only to be greatful for all the "good" in our life, but also reflect on the “bad" and recommit our energies to giving thanks and just "#giving". Happy and blessed thanksgiving to everyone who celebrates it

Brain metastasis: From etiology to ecotypes dlvr.it/TLxJTF

The role of ultra-processed food (UPF) in obesity | ⁦@NatureRevEndo⁩ —time to sound the alarm 🚨 on UPF! Nice review that focus on the biological link between UPF and Obesity nature.com/articles/s4157…

Pan-cancer human brain metastases atlas at single-cell resolution dlvr.it/TLw4ZN

In the latest issue! Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis dlvr.it/TLv0mQ

Recent research found that #temozolomide rechallenge is a common, safe, and effective second-line option for patients with MGMT-methylated, #IDHwildtype #GBM following first-line lomustine/temozolomide therapy. Read the full article in our latest issue: bit.ly/4497BUq

Policy Corner by Abdullah H. Ishaque, MD, PhD (@ahishaque), @AbdiAidid, JD, LLM, and @gelarehzadeh, MD, PhD: Lessons from the Failure of Canada’s Artificial Intelligence and Data Act nejm.ai/4ekfI3Q #AIinMedicine

Super excited to share our newest piece out today @NatureRevCancer linking age-induced metabolic reprogramming to cancer development. nature.com/articles/s4156…

🟡 July is #sarcomaawarenessmonth 🟡 Sarcoma is a rare and often overlooked cancer, but its impact is deeply felt by every patient and family it touches. @AstraZeneca and @AlexionPharmaUS, we are committed to transforming outcomes for patients with rare cancers like #sarcoma

The more potent and bespoke immunotherapy vs cancer, the better. Today's example is a neoantigen vaccine vs melanoma cell.com/cell/fulltext/…

Online Now: KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer dlvr.it/TLrhCk

Excited to lead efforts across discovery and clinical strategy to bring therapies for patients with rare cancers where the need is great and the impact can be life-changing. It’s an honor to join a team so dedicated to advancing science and making a real difference for patients

I'm happy to share that I’ve started a new position as Executive Director, Head of Rare Cancer Discovery @AstraZeneca and @AlexionPharmaUS Looking forward to what’s ahead!

Online now: Niche-specific therapeutic targeting of myeloid cells in the central nervous system dlvr.it/TKYNlp

Good update of recommendation for LGG management in the era of vorssidenib. More trials in progress @EANOassociation @EORTC @SapienzaRoma @ESTRO_RT @myESMO